CorMedix Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
CRMD on Nasdaq
Location
300 Connell Drive, Suite 4200, Berkeley Heights, NJ

Insiders trading volume in the past year

CorMedix Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joseph Todisco Chief Executive Officer, Director $1.68M +$50.7K +3.1% May 10, 2024
Myron Kaplan Director $680K Mar 5, 2024
Elizabeth Masson-Hurlburt Evp $508K -$1.57M -75.5% Nov 14, 2024
Steven W. Lefkowitz Director $374K Mar 5, 2024
Erin Mistry Chief Commercial Officer $175K Jan 12, 2024
Beth Zelnick Chief Legal Officer $174K Dec 12, 2023
Matthew T. David Chief Financial Officer $166K Jan 12, 2024
Alan Dunton Director $52.9K +$20.3K +62% Mar 5, 2024
Robert A. Stewart Director $38.2K Mar 5, 2024
Paulo F. Costa Director $34.7K May 17, 2023
Phoebe Mounts General Counsel $25K Jan 14, 2023
Gregory Scott Duncan Director Mar 5, 2024
Thomas Nusbickel EVP, Chief Commercial Officer Feb 18, 2022
Janet Dillione Director Mar 5, 2024

Recent Insider Transactions by Companies or Individuals for CorMedix Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.